Becton, Dickinson and Company (BDX) は上場企業です ヘルスケア セクターの Medical - Instruments & Supplies 業界で事業展開. 本社所在地は Franklin Lakes, NJ, アメリカ. 現CEOは Thomas E. Polen Jr..
BDX を有する IPO日 1973-02-21, 70,000 名の正社員, に上場 NYSE, 時価総額 $56.42B.
Becton, Dickinson and Company is a global medical technology manufacturer founded in 1897 that develops and sells medical supplies, devices, laboratory equipment, and diagnostic products serving healthcare institutions, physicians, life science researchers, clinical laboratories, and pharmaceutical companies worldwide. The company operates through three primary segments: BD Medical, which provides infusion therapy systems, medication management solutions, and diabetes care products; BD Life Sciences, which offers blood collection, microbiology automation, and cellular analysis systems; and BD Interventional, which supplies surgical instruments, grafts, and critical care products. With headquarters in Franklin Lakes, New Jersey, the company delivers comprehensive solutions across medical device manufacturing, laboratory diagnostics, and clinical interventions.
